Evidence map›Paper›PMID 40860748›Full record

ArticleRespirology case reports2025

COVID-19 Vaccine-Induced Severe Pneumonitis.

Tatsuro Suzuki, Hiromi Furuta, Misa Naganawa, Keiko Hayashi, Hiroko Kiyotoshi, Chiharu Ohta, Shigemitsu Ninomiya

Abstract read
In one paragraph

Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tatsuro SuzukiDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.ORCID https://orcid.org/0009-0001-9412-4447
Hiromi FurutaDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.ORCID https://orcid.org/0000-0001-7027-0354
Misa NaganawaDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.
Keiko HayashiDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.
Hiroko KiyotoshiDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.
Chiharu OhtaDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.
Shigemitsu NinomiyaDepartment of Respiratory Medicine Toyokawa City Hospital Toyokawa City Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has resulted in global morbidity, mortality, and societal disruption. COVID-19 mRNA vaccination was mandatory in many countries for a period; however, severe adverse events have been observed in some individuals who received the vaccine. We report a case of COVID-19 mRNA vaccine-induced pneumonitis in a male patient whose cytokine levels were analysed prior to admission. His serum IgE level was high (347 U/mL), and several cytokines were elevated: TNFα was 1.2 pg/mL, IL-6 was 156 pg/mL, and IL-8 was 75.0 pg/mL. The patient developed severe respiratory failure requiring ventilatory support but recovered after steroid pulse therapy.

Indexed as

COVID‐19cytokineinterstitial pneumoniavaccine

Identifiers

PMID40860748
PMCPMC12371123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.